Panretin Gel

Company
Ligand Pharmaceuticals

Approval Status
Approved June 1999

Treatment for
Infectious Diseases

Areas
Immune System

Panretin (alitretinoin) Gel, 0.1%, has been approved for the treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma.

Panretin_gel Drug Information

The Panretin_gel drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top